2 minute read
Industry News
Glaukos Submits Supplemental PMA for iStent
Glaukos sent a supplemental premarket approval application to the US FDA for the iStent® infinite Trabecular Micro-Bypass System. Intended for refractory glaucoma treatment, the iStent infinite Trabecular Micro-Bypass System Model iS3 is a sterile, single-use injector system preloaded with three G2-W stents and designed to deliver the stents into Schlemm’s canal. The three G2-W stents are heparin-coated and manufactured from implant-grade titanium. Once in place, the stents are designed to lower IOP by restoring the natural, physiological outflow of aqueous humour. The company’s two-stent iStent inject® W Trabecular Micro-Bypass System already received US FDA approval for reducing IOP in adult mild-to-moderate primary open-angle glaucoma patients undergoing concomitant cataract surgery.
www.glaukos.com
HAAG-STREIT MR Q COMBO LASER SYSTEM UK LAUNCH
Haag-Streit announced the launch of its Swiss-engineered MR Q Combo device in the UK market. The space-saving MR Q Combo is a specially designed slit lamp offering the option to safely combine the MR Q YAG 1064nm laser with either a Merilas 532a, Merilas 532nm, or Merilas 577nm short pulse laser. The latter of the two configurations deliver microsecond pulses for subthreshold retinal treatments. Safe handling of the two lasers is ensured by the specially designed slit lamp adapter.
https://hsuk.co/MRQ
ZEISS ANNOUNCES SEVERAL NEW PRODUCTS
ZEISS introduced several new products and updates in a three-day online event. The company emphasised integration of digital systems and smoothing workflow as the unifying themes, referring to the ‘ZEISS Medical Ecosystem’.
For cataract surgery, the company introduced the QUATERA® 700 phaco system featuring the QUATTRO Pump, which delivers chamber stability independent of intraocular pressure (IOP) and flow. According to the company, the QUATERA 700 increases a surgeon’s workflow efficiency from the clinic to the operating room, enabling one digitally integrated surgical workflow. Also new on the cataract front, the EYEGUIDE® patient software application, designed to help patients and clinics stay connected through the entire cataract treatment process. An app for surgeons, the Surgery Optimizer application provides a way to utilise surgical videos to enable selftraining of physicians and standardization of surgical techniques. Speakers also presented the latest information on the new aspheric CT LUCIA 621 monofocal along with the OPTIKIT, a customizable surgical pack.
“It is our mission to contribute to the progress of medicine, enabling more efficient and cost-effective treatments and providing access to high-quality medical care to as many people as possible. Our investment in digital technology will continue to make the adoption of digitalization easy and intuitive,” said Dr Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.
www.zeiss.com/med